BR112022016241A2 - Composições de ginsenosídeo - Google Patents
Composições de ginsenosídeoInfo
- Publication number
- BR112022016241A2 BR112022016241A2 BR112022016241A BR112022016241A BR112022016241A2 BR 112022016241 A2 BR112022016241 A2 BR 112022016241A2 BR 112022016241 A BR112022016241 A BR 112022016241A BR 112022016241 A BR112022016241 A BR 112022016241A BR 112022016241 A2 BR112022016241 A2 BR 112022016241A2
- Authority
- BR
- Brazil
- Prior art keywords
- ginsenesiide
- compositions
- individual
- relates
- american ginseng
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2004121.6A GB202004121D0 (en) | 2020-03-20 | 2020-03-20 | Improved compositions |
| GBGB2005288.2A GB202005288D0 (en) | 2020-04-09 | 2020-04-09 | Improved compositions |
| PCT/EP2021/056788 WO2021185890A1 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022016241A2 true BR112022016241A2 (pt) | 2022-10-11 |
Family
ID=75108332
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022016241A BR112022016241A2 (pt) | 2020-03-20 | 2021-03-17 | Composições de ginsenosídeo |
| BR112022015826A BR112022015826A2 (pt) | 2020-03-20 | 2021-03-17 | Composições de ginsenosídeo |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022015826A BR112022015826A2 (pt) | 2020-03-20 | 2021-03-17 | Composições de ginsenosídeo |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230124503A1 (https=) |
| EP (2) | EP4121061A1 (https=) |
| JP (2) | JP7850670B2 (https=) |
| CN (2) | CN115315264A (https=) |
| AU (2) | AU2021238643A1 (https=) |
| BR (2) | BR112022016241A2 (https=) |
| CA (2) | CA3174698A1 (https=) |
| WO (2) | WO2021185897A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7850670B2 (ja) * | 2020-03-20 | 2026-04-23 | ジボダン エス エー | ギンセノシド組成物 |
| JP2023161983A (ja) * | 2022-04-26 | 2023-11-08 | 石川県公立大学法人 | サポニンを含む酪酸産生菌増殖能向上組成物、腸内常在菌増殖能向上組成物、乳酸菌増殖能向上組成物及びビフィズス菌増殖能向上組成物 |
| CN117224553B (zh) * | 2023-11-02 | 2025-08-12 | 浙江大学 | 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用 |
| CN117752706B (zh) * | 2023-12-20 | 2025-10-14 | 浙江天皇药业有限公司 | 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用 |
| WO2025261873A1 (en) | 2024-06-20 | 2025-12-26 | Givaudan Sa | Improvements in or relating to compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040202731A1 (en) * | 2003-04-08 | 2004-10-14 | Gow Robert T. | Rosmarinic acid composition |
| US20100278944A1 (en) | 2009-05-04 | 2010-11-04 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| US9956241B2 (en) * | 2009-05-04 | 2018-05-01 | Naturex, S.A. | Application of American Ginseng to enhance neurocognitive function |
| US10456436B2 (en) * | 2013-11-04 | 2019-10-29 | Wen Luan Wendy Hsiao | Use of herbal saponins to regulate gut microflora |
| SG11202000258TA (en) | 2017-07-18 | 2020-02-27 | Senescence Life Sciences Pte Ltd | Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function |
| CN110613802A (zh) | 2018-06-20 | 2019-12-27 | 珠海岐微生物科技有限公司 | 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途 |
| CN109432304A (zh) * | 2018-12-03 | 2019-03-08 | 杭州胡庆余堂药业有限公司 | 一种含铁皮石斛组合物在药物制备中的应用 |
| JP7850670B2 (ja) | 2020-03-20 | 2026-04-23 | ジボダン エス エー | ギンセノシド組成物 |
-
2021
- 2021-03-17 JP JP2022556000A patent/JP7850670B2/ja active Active
- 2021-03-17 CA CA3174698A patent/CA3174698A1/en active Pending
- 2021-03-17 CN CN202180022225.5A patent/CN115315264A/zh active Pending
- 2021-03-17 AU AU2021238643A patent/AU2021238643A1/en active Pending
- 2021-03-17 AU AU2021238639A patent/AU2021238639A1/en active Pending
- 2021-03-17 EP EP21712999.8A patent/EP4121061A1/en active Pending
- 2021-03-17 CN CN202180022249.0A patent/CN115315266A/zh active Pending
- 2021-03-17 WO PCT/EP2021/056803 patent/WO2021185897A1/en not_active Ceased
- 2021-03-17 US US17/905,849 patent/US20230124503A1/en active Pending
- 2021-03-17 US US17/905,868 patent/US20230129389A1/en active Pending
- 2021-03-17 EP EP21713906.2A patent/EP4121076A1/en active Pending
- 2021-03-17 JP JP2022555990A patent/JP7808042B2/ja active Active
- 2021-03-17 WO PCT/EP2021/056788 patent/WO2021185890A1/en not_active Ceased
- 2021-03-17 CA CA3174699A patent/CA3174699A1/en active Pending
- 2021-03-17 BR BR112022016241A patent/BR112022016241A2/pt unknown
- 2021-03-17 BR BR112022015826A patent/BR112022015826A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN115315266A (zh) | 2022-11-08 |
| JP7850670B2 (ja) | 2026-04-23 |
| CA3174699A1 (en) | 2021-09-23 |
| WO2021185890A1 (en) | 2021-09-23 |
| US20230129389A1 (en) | 2023-04-27 |
| JP2023518064A (ja) | 2023-04-27 |
| BR112022015826A2 (pt) | 2022-10-04 |
| US20230124503A1 (en) | 2023-04-20 |
| AU2021238639A1 (en) | 2022-09-15 |
| EP4121061A1 (en) | 2023-01-25 |
| EP4121076A1 (en) | 2023-01-25 |
| CA3174698A1 (en) | 2021-09-23 |
| WO2021185897A1 (en) | 2021-09-23 |
| AU2021238643A1 (en) | 2022-10-20 |
| JP2023519189A (ja) | 2023-05-10 |
| CN115315264A (zh) | 2022-11-08 |
| JP7808042B2 (ja) | 2026-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022016241A2 (pt) | Composições de ginsenosídeo | |
| MX2018011348A (es) | Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades. | |
| HK1244616A2 (zh) | 一组保湿组合及其在制备保湿化妆品的应用 | |
| WO2004089357A3 (en) | Anti-fungal formulation of triterpene and essential oil | |
| BR112017025331A2 (pt) | composições cosméticas que compreendem o suco prensado de echinacia roxa | |
| MX2018002990A (es) | Uso de la akkermansia pasteurizada para tratar trastornos metabolicos. | |
| WO2008098192A3 (en) | Compositions and methods for treating neuropathy | |
| BRPI1009842B8 (pt) | uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas | |
| UY37952A (es) | Formulaciones de un inhibidor de la quinasa trk macrocíclica | |
| ZA201805792B (en) | Taurine and aloe synergistic anti-irritant compositions and methods | |
| BR112021019262A2 (pt) | Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose | |
| BR112018076770A2 (pt) | composição, método de preparação da composição, uso da composição, combustível obtido a partir da composição, e compósito | |
| BR112018007560A2 (pt) | composição cosmética tendo bactérias probióticas | |
| MX2015006370A (es) | Suplementos herbales y metodos para utilizar los mismos. | |
| WO2018231988A3 (en) | COSMETIC COMPOSITIONS AND METHODS FOR USE IN SKIN REFRESH | |
| BR112022018009A2 (pt) | Composição, método para preparar uma formulação e uso de trietil citrato | |
| BR0317420A (pt) | Luva tratada com camomila/aloe vera | |
| WO2014174114A3 (en) | Hair dyeing process using henna and then indigo and an oil and/or butter | |
| BR112022000229A2 (pt) | Composição para uso no tratamento da perda de cabelo | |
| BR112022025105A2 (pt) | Método para o tratamento de câncer cervical em um indivíduo, conjugado anticorpo-fármaco, e, uso de um conjugado anticorpo-fármaco | |
| CO2020004801A2 (es) | Uso de suplementos de aminoácidos para mejorar la síntesis de proteínas musculares | |
| BR112018009502A2 (pt) | polifenóis de cacau e fibra dietética solúvel para uso no tratamento ou prevenção de distúrbios associados com um número acima do normal de granulócitos em um tecido | |
| MX2018003086A (es) | Composicion que tiene residuo reducido. | |
| CO2024001711A2 (es) | Anticuerpos anti hla-g | |
| PH12017502145A1 (en) | Composition and uses thereof |